Authors: Arya Aminorroaya, Akshay Khunte, Lovedeep Singh Dhingra, Veer Sangha, Sounok Sen, Norrisa Haynes, Harlan M Krumholz, Rohan Khera

Funding: The study was supported by Bristol Myers Squibb. The funder had no role in the study design and execution or in the preparation, approval, and decision to submit the publication.

Disclosures: Dr. Khera is an Associate Editor at JAMA and receives research grant support, through Yale, from Bristol‐Myers Squibb and Novo Nordisk. He is a coinventor of U.S. Pending Patent Applications 63/177,117, 63/346,610, and 63/428,569, unrelated to the current work. He receives support from the Blavatnik Foundation through the Blavatnik Fund for Innovation at Yale. He is a co-founder of Evidence2Health, a precision health platform to improve evidence-based cardiovascular care. Dr. Krumholz reported receiving expenses and/or personal fees from UnitedHealthcare, Element Science, Aetna, Reality Labs, Tesseract/4Catalyst, F-Prime, the Siegfried & Jensen law firm, the Arnold & Porter law firm, and the Martin Baughman law firm; being a co-founder of Refactor Health and Hugo Health; and being associated with contracts through Yale New Haven Hospital from the Centers for Medicare & Medicaid Services and through Yale University from Johnson & Johnson outside the submitted work. The remaining authors have no disclosures to report.